Private company
Acutus Medical, Inc.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
5.0%Gross margin3
-0.3%Operating margin3
-47.4%Net margin3
181.4%Revenue growth, 20243
-$31.8MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Cost of revenue65¢$19.1M
- Selling, general and admin35¢$10.4M
Out of $20.2M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.8M4 | $8.5M5 | $17.3M6 | $3.0M7 | $7.2M3 | $20.2M3 | |
| Cost of revenue | $9.2M4 | $15.9M5 | $32.9M6 | $4.9M7 | $10.3M3 | $19.1M3 | |
| Gross profit | -$1.9M7 | -$3.1M3 | $1.0M3 | ||||
| Research and development | $23.0M4 | $33.5M5 | $36.7M6 | $3.1M7 | $3.5M3 | $03 | |
| Selling, general and admin | $26.8M4 | $50.4M5 | $63.5M6 | $20.3M7 | $14.1M3 | $10.4M3 | |
| Operating income | -$72.6M4 | -$91.3M5 | -$112.1M6 | $41.0M7 | -$11.7M3 | -$57.0K3 | |
| Interest | $22.3M4 | $5.5M5 | $5.7M6 | $5.1M7 | $5.7M7 | ||
| Income tax | $04 | $23.0K5 | $06 | $15.0K7 | $63.0K3 | $03 | |
| Net income | -$97.0M4 | -$102.0M8 | -$117.7M6 | -$39.6M7 | -$81.7M3 | -$9.5M3 | |
| Earnings per share | -$8.945 | -$4.116 | -$1.407 | -$2.813 | -$0.323 | ||
| Earnings per share (diluted) | -$8.945 | -$4.116 | -$1.407 | -$2.813 | -$0.323 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash | $9.8M4 | $9.5M4 | $25.2M5 | $24.1M6 | $25.6M7 | $19.2M3 | $14.0M3 |
| Current assets | $82.5M4 | $151.4M5 | $126.3M6 | $117.9M7 | $46.3M3 | $25.6M3 | |
| Total assets | $105.5M4 | $192.5M5 | $169.8M6 | $133.4M7 | $54.0M3 | $28.6M3 | |
| Current liabilities | $31.9M4 | $21.9M5 | $18.5M6 | $19.9M7 | $18.9M3 | $12.4M3 | |
| Long-term debt | $38.2M4 | $39.0M5 | $40.4M6 | $34.4M7 | $32.7M3 | $25.6M3 | |
| Total liabilities | $77.9M4 | $66.0M5 | $64.1M6 | $58.4M7 | $54.8M3 | $40.2M3 | |
| Shareholders’ equity | -$131.8M4 | -$225.8M5 | $126.6M6 | $105.7M7 | $75.0M3 | -$879.0K3 | -$11.6M3 |
| Shares outstanding | 695.9K shares4 | 28.0M shares5 | 28.0M shares6 | 28.6M shares7 | 29.3M shares3 | 29.9M shares3 |
Recent filings
- Mar 24, 20258-K
- Mar 24, 202510-K
- Jan 28, 20254
- Jan 21, 20258-K
- Dec 4, 20248-K
- Nov 15, 20248-K
- Nov 14, 20248-K
- Nov 14, 202410-Q
- Oct 17, 20248-K
- Aug 8, 20248-K
- Aug 8, 202410-Q
- Jun 14, 20248-K
- May 17, 20248-K
- May 9, 20248-K
- May 9, 202410-Q
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11